Ensayos clínicos de Depresión en Ohio
26 estudios sobre Depresión buscan participantes en Ohio.
Ciudades en Ohio
Texto oficial del estudio (inglés)
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Independence
- Seaport Investigator Site, North Canton
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07065240A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Insight Clinical Trials, Independence
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Columbus
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07610473NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Mason
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06911112E-Mindfulness Approaches for Living After Breast Cancer
- Indu and Raj Soin Medical Center, Beavercreek
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
- y 16 más
ReclutandoFase 3
Edades de 18 a 50 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06748222Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
- Lindner Center of Hope, Mason
ReclutandoFase 1/2
Edades de 18 a 60 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06795451A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Neuro-Behavioral Clinical Research, North Canton
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06775379Developing Resilience and Anxiety Management Through the Arts
- Case Western Reserve University, Cleveland
Reclutando
Edades de 8 a 17 · Todos los sexos · Actualizado el 31 jul 2026 · NCT07033052A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Cleveland Clinic - Cleveland /ID# 276309, Cleveland
- CincyScience /ID# 226318, West Chester
ReclutandoFase 3
Edades de 10 a 17 · Todos los sexos · Actualizado el 27 jul 2026 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jul 2026 · NCT06966401A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
- The Ohio State University Department of Psychiatry, Columbus
ReclutandoFase 2
Edades de 21 a 65 · Todos los sexos · Actualizado el 23 jul 2026 · NCT06820723Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety
- Ohio State University Wexner Medical Center, Columbus
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 jul 2026 · NCT07717541TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Cincinnati Children's Hospital Medical Center, Cincinnati
ReclutandoEstudio observacional
18 Months – 11 Years · Todos los sexos · Actualizado el 6 jul 2026 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- The Ohio State University, Columbus
- Charak Center for Health and Wellness, Garfield Heights
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT03887715Teenthrive 2: Treatments for Improving Mood in Teens
- Nationwide Children's Hospital, Columbus
Reclutando
Edades de 12 a 18 · Todos los sexos · Actualizado el 10 jun 2026 · NCT07475845Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 may 2026 · NCT07216404A Precision Medicine Approach to Target Engagement for Emotion Regulation
- Ohio State University, Columbus
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 may 2026 · NCT05651295A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- The Ohio State University, Columbus
- Neuro Behavioral Clinical Research, Inc., North Canton
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 may 2026 · NCT06524830Virtual Patient Groups for Sarcoidosis Associated Fatigue
- Cleveland Clinic, Cleveland
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 abr 2026 · NCT07073963Positive Processes and Transition to Health - Single-Session (PATH-SS)
- Case Western Reserve University, Cleveland
ReclutandoIndica pago para participantes
Edades de 18 a 65 · Todos los sexos · Actualizado el 22 abr 2026 · NCT06900712Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth
- University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, Cincinnati
ReclutandoFase 3
Edades de 15 a 24 · Todos los sexos · Actualizado el 11 mar 2026 · NCT07464886Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Cincinnati Children's Hospital Medical Center, Cincinnati
Reclutando
Edades de 12 a 22 · Todos los sexos · Actualizado el 30 oct 2025 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Avon Lake
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT06786624Mechanisms of Rumination Change in Adolescent Depression
- Nationwide Children's Hospital, Columbus
- The Ohio State University, Columbus
Reclutando
Edades de 14 a 17 · Todos los sexos · Actualizado el 11 ago 2025 · NCT03859297A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Cincinnati
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 ene 2025 · NCT06223880De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.